Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/121468
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Clayton, P. | - |
dc.contributor.author | Mcdonald, S. | - |
dc.contributor.author | Russ, G. | - |
dc.contributor.author | Chadban, S. | - |
dc.date.issued | 2013 | - |
dc.identifier.citation | Nephrology, 2013, vol.18, iss.Suppl. 1, pp.43-43 | - |
dc.identifier.issn | 1320-5358 | - |
dc.identifier.issn | 1440-1797 | - |
dc.identifier.uri | http://hdl.handle.net/2440/121468 | - |
dc.description | Abstract #111 | - |
dc.description.abstract | Background: Declining rates of acute rejection (AR) and the high rate of 1-year graft survival among patients with AR have prompted re-examination of AR as an outcome in the clinic and in trials. Yet AR and its treatment may directly or indirectly affect longer-term outcomes for kidney transplant recipients. Methods: To understand the long-term effect of AR on outcomes, we analyzed data from the Australia and New Zealand Dialysis and Transplant Registry, including 13,614 recipients of a primary kidney-only transplant between 1997 and 2017 with at least 6 months of graft function. The associations between AR within 6 months post-transplant and subsequent cause-specific graft loss and death were determined using Cox models adjusted for baseline donor, recipient, and transplant characteristics. Results: AR occurred in 2906 recipients (21.4%) and was associated with graft loss attributed to chronic allograft nephropathy (hazard ratio [HR], 1.39; 95% confidence interval [95% CI], 1.23 to 1.56) and recurrent AR beyond month 6 (HR, 1.85; 95% CI, 1.39 to 2.46). Early AR was also associated with death with a functioning graft (HR, 1.22; 95% CI, 1.08 to 1.36), and with death due to cardiovascular disease (HR, 1.30; 95% CI, 1.11 to 1.53) and cancer (HR, 1.35; 95% CI, 1.12 to 1.64). Sensitivity analyses restricted to subgroups with either biopsy-proven, antibody-mediated, or vascular rejection, or stratified by treatment response produced similar results. Conclusions: AR is associated with increased risks of longer-term graft failure and death, particularly death from cardiovascular disease and cancer. The results suggest AR remains an important short-term outcome to monitor in kidney transplantation and clinical trials. | - |
dc.description.statementofresponsibility | P Clayton, S McDonald, G Russ and S Chadban | - |
dc.language.iso | en | - |
dc.publisher | Wiley-Blackwell | - |
dc.rights | © 2013 The Authors Nephrology. © 2013 Asian Pacific Society of Nephrology, | - |
dc.subject | Kidney transplantation | - |
dc.title | Long-term outcomes following acute rejection in kidney transplant recipients: an ANZDATA analysis | - |
dc.type | Conference item | - |
dc.contributor.conference | 49th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (9 Sep 2013 - 13 Sep 2013 : Brisbane, QLD) | - |
dc.identifier.doi | 10.1111/nep.12121 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Clayton, P. [0000-0001-9190-6753] | - |
dc.identifier.orcid | Mcdonald, S. [0000-0001-6103-1386] | - |
Appears in Collections: | Aurora harvest 4 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.